IBDEI0PH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11369,0)
 ;;=H21.261^^77^731^26
 ;;^UTILITY(U,$J,358.3,11369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11369,1,3,0)
 ;;=3^Iris Atrophy,Essential,Right Eye
 ;;^UTILITY(U,$J,358.3,11369,1,4,0)
 ;;=4^H21.261
 ;;^UTILITY(U,$J,358.3,11369,2)
 ;;=^5005199
 ;;^UTILITY(U,$J,358.3,11370,0)
 ;;=H21.262^^77^731^27
 ;;^UTILITY(U,$J,358.3,11370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11370,1,3,0)
 ;;=3^Iris Atrophy,Essential,Left Eye
 ;;^UTILITY(U,$J,358.3,11370,1,4,0)
 ;;=4^H21.262
 ;;^UTILITY(U,$J,358.3,11370,2)
 ;;=^5005200
 ;;^UTILITY(U,$J,358.3,11371,0)
 ;;=H21.231^^77^731^28
 ;;^UTILITY(U,$J,358.3,11371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11371,1,3,0)
 ;;=3^Degeneration of Iris,Pigmentary,Right Eye
 ;;^UTILITY(U,$J,358.3,11371,1,4,0)
 ;;=4^H21.231
 ;;^UTILITY(U,$J,358.3,11371,2)
 ;;=^5005187
 ;;^UTILITY(U,$J,358.3,11372,0)
 ;;=H21.232^^77^731^29
 ;;^UTILITY(U,$J,358.3,11372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11372,1,3,0)
 ;;=3^Degeneration of Iris,Pigmentary,Left Eye
 ;;^UTILITY(U,$J,358.3,11372,1,4,0)
 ;;=4^H21.232
 ;;^UTILITY(U,$J,358.3,11372,2)
 ;;=^5005188
 ;;^UTILITY(U,$J,358.3,11373,0)
 ;;=H57.00^^77^731^30
 ;;^UTILITY(U,$J,358.3,11373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11373,1,3,0)
 ;;=3^Anomaly of Pupillary Function,Unspec
 ;;^UTILITY(U,$J,358.3,11373,1,4,0)
 ;;=4^H57.00
 ;;^UTILITY(U,$J,358.3,11373,2)
 ;;=^5006375
 ;;^UTILITY(U,$J,358.3,11374,0)
 ;;=D31.42^^77^731^31
 ;;^UTILITY(U,$J,358.3,11374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11374,1,3,0)
 ;;=3^Benign Neopl of Ciliary Body,Left Eye
 ;;^UTILITY(U,$J,358.3,11374,1,4,0)
 ;;=4^D31.42
 ;;^UTILITY(U,$J,358.3,11374,2)
 ;;=^5002125
 ;;^UTILITY(U,$J,358.3,11375,0)
 ;;=D31.41^^77^731^32
 ;;^UTILITY(U,$J,358.3,11375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11375,1,3,0)
 ;;=3^Benign Neopl of Ciliary Body,Right Eye
 ;;^UTILITY(U,$J,358.3,11375,1,4,0)
 ;;=4^D31.41
 ;;^UTILITY(U,$J,358.3,11375,2)
 ;;=^5002124
 ;;^UTILITY(U,$J,358.3,11376,0)
 ;;=C69.41^^77^731^33
 ;;^UTILITY(U,$J,358.3,11376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11376,1,3,0)
 ;;=3^Malig Neopl of Ciliary Body,Right Eye
 ;;^UTILITY(U,$J,358.3,11376,1,4,0)
 ;;=4^C69.41
 ;;^UTILITY(U,$J,358.3,11376,2)
 ;;=^5001279
 ;;^UTILITY(U,$J,358.3,11377,0)
 ;;=C69.42^^77^731^34
 ;;^UTILITY(U,$J,358.3,11377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11377,1,3,0)
 ;;=3^Malig Neopl of Ciliary Body,Left Eye
 ;;^UTILITY(U,$J,358.3,11377,1,4,0)
 ;;=4^C69.42
 ;;^UTILITY(U,$J,358.3,11377,2)
 ;;=^5001280
 ;;^UTILITY(U,$J,358.3,11378,0)
 ;;=H35.061^^77^731^35
 ;;^UTILITY(U,$J,358.3,11378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11378,1,3,0)
 ;;=3^Retinal Vasculitis,Right Eye
 ;;^UTILITY(U,$J,358.3,11378,1,4,0)
 ;;=4^H35.061
 ;;^UTILITY(U,$J,358.3,11378,2)
 ;;=^5005602
 ;;^UTILITY(U,$J,358.3,11379,0)
 ;;=H35.062^^77^731^36
 ;;^UTILITY(U,$J,358.3,11379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11379,1,3,0)
 ;;=3^Retinal Vasculitis,Left Eye
 ;;^UTILITY(U,$J,358.3,11379,1,4,0)
 ;;=4^H35.062
 ;;^UTILITY(U,$J,358.3,11379,2)
 ;;=^5005603
 ;;^UTILITY(U,$J,358.3,11380,0)
 ;;=H20.011^^77^731^2
 ;;^UTILITY(U,$J,358.3,11380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11380,1,3,0)
 ;;=3^Iridocyclitis,Primary,Right Eye
 ;;^UTILITY(U,$J,358.3,11380,1,4,0)
 ;;=4^H20.011
 ;;^UTILITY(U,$J,358.3,11380,2)
 ;;=^5005134
 ;;^UTILITY(U,$J,358.3,11381,0)
 ;;=H20.012^^77^731^3
